CNTB
NASDAQ · Biotechnology
Connect Biopharma Holdings L
$1.08
+0.00 (+0.00%)
Open$1.08
Previous Close$1.08
Day High$1.11
Day Low$1.05
52W High$3.82
52W Low$1.06
Volume—
Avg Volume2.65M
Market Cap68.01M
P/E Ratio—
EPS$-1.20
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+1,803.7% upside
Current
$1.08
$1.08
Target
$20.56
$20.56
$15.18
$20.56 avg
$23.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 69.9K | 69.44M | 70.73M |
| Net Income | -63,359,449 | 4.31M | 5.04M |
| Profit Margin | -86,687.5% | 6.2% | 7.1% |
| EBITDA | -65,514,229 | 5.85M | 6.49M |
| Free Cash Flow | — | 3.99M | 3.58M |
| Rev Growth | — | +2.8% | -4.7% |
| Debt/Equity | — | 0.90 | 0.87 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $263.29 | -1.12% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $423.64 | +1.32% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $151.28 | -0.61% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $526.73 | -0.18% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $750.51 | -0.23% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $254.07 | -0.51% | 41.4 | 33.44B |